Extended duration of therapy with peginterferon alpha 2b and weight based ribavirin in HCV patients with genotype 3 infection

Research output: Contribution to conferenceOther

Original languageEnglish
Pages1036A-1037A
Number of pages2
Publication statusPublished - 2009

Cite this